FTC's Past Advocacy on PBMs is Misguided
On July 20, 2023, David Balto made a statement regarding FTC's past advocacy on PBMs at the Commission's Open Meeting. He argued that the...
David Balto Sends Letter to HELP Committee Regarding Need for PBM Reform
The letter states that in crafting legislation to benefit taxpayers and consumers and erect long-needed guardrails on the PBMs that...
Unions and Consumer Groups Submit Comments to FTC Encouraging it to Investigate PBM Practices
On May 25, AFSCME, American Family Voices, Consumer Action, Consumer Federation of America, Doctors for America, Treatment Action Group,...
Congress: Target the Middlemen Who Drive Up Drug Costs
David Balto authored an opinion in Healthcare Dive on why Congress should target PBMs, the middlemen, that drive up drugs costs. See the...
Consumer Groups Ask FTC to Implement Rules Against Pharma Rebate Walls
Families USA, SEIU, AFSCME, Public Interest Research Group, Consumer Action, Alliance for Retired Americans, Doctors for America,...
FTC’s current approach to pharmaceutical merger enforcement is too lax.
On June 25, 2021, Consumer groups and unions including Families USA, Public Interest Research Group, Services Employees International...
Consumer Groups Submit Letter to Chairwoman Maloney Thanking Her For Her Work on AbbVie
On June 16, 2021, Consumer Groups and unions including American Federation of State, County, and Municipal Employees, Alliance for...
Secretary of HHS Becerra May Play Large Role In Combatting Rebate Walls.
The following article focuses on anti-competitive practices, and the role Secretary of HHS Becerra may play in addressing this issue....
Consumer Groups Recommend Increased Enforcement Against Pharmaceutical Rebate Walls
On February 18, 2021, Consumer Action and U.S. Public Interest Research Group submitted recommendations to the Biden/Harris Transition...
Consumer Groups and Unions Submit Letter in Support of PBM Bill Lowering Drug Prices
Yesterday, December 16th, a number of consumer groups and unions submitted a letter in support of H.R. 5304, a bill to regulate pharmacy...
